Ezabenlimab with induction chemotherapy and adaptive chemoradiotherapy in stage 3 squamous cell anal carcinoma – Authors' reply

The Lancet Oncology 2026

View at publisher

Authors: Christophe Borg, Stefano Chong Hun Kim

DOI: 10.1016/s1470-2045(26)00012-4

Cited by: 0

References: 3

Fields of Study & Subjects

Colorectal and Anal Carcinomas Head and Neck Cancer Studies Colorectal Cancer Surgical Treatments

References 3